Atria Investments Inc Sells 1,280 Shares of Colgate-Palmolive (NYSE:CL)

Atria Investments Inc lowered its position in Colgate-Palmolive (NYSE:CL) by 1.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 72,785 shares of the company’s stock after selling 1,280 shares during the period. Atria Investments Inc’s holdings in Colgate-Palmolive were worth $6,617,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the company. Assetmark Inc. grew its holdings in shares of Colgate-Palmolive by 295.1% in the fourth quarter. Assetmark Inc. now owns 16,280 shares of the company’s stock worth $1,480,000 after acquiring an additional 12,160 shares during the period. Cypress Capital Group grew its holdings in shares of Colgate-Palmolive by 12.6% in the fourth quarter. Cypress Capital Group now owns 29,647 shares of the company’s stock worth $2,695,000 after acquiring an additional 3,307 shares during the period. Jag Capital Management LLC grew its holdings in shares of Colgate-Palmolive by 0.7% in the fourth quarter. Jag Capital Management LLC now owns 33,773 shares of the company’s stock worth $3,070,000 after acquiring an additional 227 shares during the period. Commerzbank Aktiengesellschaft FI grew its holdings in shares of Colgate-Palmolive by 32.4% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 18,087 shares of the company’s stock worth $1,644,000 after acquiring an additional 4,422 shares during the period. Finally, Synergy Investment Management LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter worth $75,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE:CL opened at $93.30 on Friday. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The company has a market capitalization of $75.72 billion, a P/E ratio of 26.51, a P/E/G ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The business’s 50-day moving average is $88.74 and its 200 day moving average is $95.26.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company earned $0.87 EPS. On average, equities research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a $0.50 dividend. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.14%. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Wall Street Analysts Forecast Growth

CL has been the subject of several recent research reports. Barclays cut their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Piper Sandler cut their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. Royal Bank of Canada reissued a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Stifel Nicolaus cut their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Finally, JPMorgan Chase & Co. cut their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $101.61.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.